Standard

Повышение флюоресценции сетчатки под влиянием кур-кумина как новое направле-ние в ранней диагностике болезни Альцгеймера. / Струментова, Е.С.; Лобзин, Владимир Юрьевич; Мальцев, Д.С.; Бурнашева, М.А.; Сергеева, Татьяна Васильевна; Буряк, Андрей Борисович.

в: ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА, Том 125, № 4-2, 27.05.2025, стр. 19-25.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

APA

Vancouver

Author

BibTeX

@article{7f81084b31804005a3af5557df8f9901,
title = "Повышение флюоресценции сетчатки под влиянием кур-кумина как новое направле-ние в ранней диагностике болезни Альцгеймера",
abstract = "Objective. To search for an effective method for early diagnosis of Alzheimer{\textquoteright}s disease (AD) and mild cognitive impairment (MCI) of amnestic type using scanning laser ophthalmoscopy as a safe and widely available examination method. Material and methods. The study included 45 patients: 20 with AD, 10 with MCI, and 15 healthy control subjects. The patients were examined to visualize amyloid deposition in the retina using a solid lipid food curcumin ligand and a modified scanning laser oph-thalmoscope, with a total of 63 observations since not all subjects were eligible for assessment of the retinas of both eyes. All patients underwent a neurological and ophthalmological examination, neuropsychological testing (MMSE, FCSRT, Clock Drawing test), brain MRI for visual assessment of atrophic changes (using global cortical atrophy scales, GCA and the medial temporal lobe atrophy, MTA), as well as confocal scanning laser ophthalmoscopy at two timepoints before and during curcumin administration. A semi-au-tomated calculation of the area increase multiplicity (S) and the number (N) of particles with peak brightness (PPB) was performed. Results. In patients with AD, the following findings were obtained after taking curcumin: NPPB 167% [129; 258] (p=0.1) and SPPB 198% [148; 230] (p=0.007); MCI: NPPB 123% [114; 157] (p=0.15) and SPPB 129% [110; 140] (p=0.08). Conclusion. The results indicate an increased deposition of beta-amyloid protein in the retina in patients with AD and expand the possibilities of its early diagnosis.",
keywords = "Alzheimer{\textquoteright}s disease, beta-amyloid protein, curcumin, eye, mild cognitive impairment, retina, scanning laser ophthalmoscopy",
author = "Е.С. Струментова and Лобзин, {Владимир Юрьевич} and Д.С. Мальцев and М.А. Бурнашева and Сергеева, {Татьяна Васильевна} and Буряк, {Андрей Борисович}",
year = "2025",
month = may,
day = "27",
doi = "10.17116/jnevro202512504219",
language = "русский",
volume = "125",
pages = "19--25",
journal = "ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА",
issn = "1997-7298",
publisher = "Медицина",
number = "4-2",

}

RIS

TY - JOUR

T1 - Повышение флюоресценции сетчатки под влиянием кур-кумина как новое направле-ние в ранней диагностике болезни Альцгеймера

AU - Струментова, Е.С.

AU - Лобзин, Владимир Юрьевич

AU - Мальцев, Д.С.

AU - Бурнашева, М.А.

AU - Сергеева, Татьяна Васильевна

AU - Буряк, Андрей Борисович

PY - 2025/5/27

Y1 - 2025/5/27

N2 - Objective. To search for an effective method for early diagnosis of Alzheimer’s disease (AD) and mild cognitive impairment (MCI) of amnestic type using scanning laser ophthalmoscopy as a safe and widely available examination method. Material and methods. The study included 45 patients: 20 with AD, 10 with MCI, and 15 healthy control subjects. The patients were examined to visualize amyloid deposition in the retina using a solid lipid food curcumin ligand and a modified scanning laser oph-thalmoscope, with a total of 63 observations since not all subjects were eligible for assessment of the retinas of both eyes. All patients underwent a neurological and ophthalmological examination, neuropsychological testing (MMSE, FCSRT, Clock Drawing test), brain MRI for visual assessment of atrophic changes (using global cortical atrophy scales, GCA and the medial temporal lobe atrophy, MTA), as well as confocal scanning laser ophthalmoscopy at two timepoints before and during curcumin administration. A semi-au-tomated calculation of the area increase multiplicity (S) and the number (N) of particles with peak brightness (PPB) was performed. Results. In patients with AD, the following findings were obtained after taking curcumin: NPPB 167% [129; 258] (p=0.1) and SPPB 198% [148; 230] (p=0.007); MCI: NPPB 123% [114; 157] (p=0.15) and SPPB 129% [110; 140] (p=0.08). Conclusion. The results indicate an increased deposition of beta-amyloid protein in the retina in patients with AD and expand the possibilities of its early diagnosis.

AB - Objective. To search for an effective method for early diagnosis of Alzheimer’s disease (AD) and mild cognitive impairment (MCI) of amnestic type using scanning laser ophthalmoscopy as a safe and widely available examination method. Material and methods. The study included 45 patients: 20 with AD, 10 with MCI, and 15 healthy control subjects. The patients were examined to visualize amyloid deposition in the retina using a solid lipid food curcumin ligand and a modified scanning laser oph-thalmoscope, with a total of 63 observations since not all subjects were eligible for assessment of the retinas of both eyes. All patients underwent a neurological and ophthalmological examination, neuropsychological testing (MMSE, FCSRT, Clock Drawing test), brain MRI for visual assessment of atrophic changes (using global cortical atrophy scales, GCA and the medial temporal lobe atrophy, MTA), as well as confocal scanning laser ophthalmoscopy at two timepoints before and during curcumin administration. A semi-au-tomated calculation of the area increase multiplicity (S) and the number (N) of particles with peak brightness (PPB) was performed. Results. In patients with AD, the following findings were obtained after taking curcumin: NPPB 167% [129; 258] (p=0.1) and SPPB 198% [148; 230] (p=0.007); MCI: NPPB 123% [114; 157] (p=0.15) and SPPB 129% [110; 140] (p=0.08). Conclusion. The results indicate an increased deposition of beta-amyloid protein in the retina in patients with AD and expand the possibilities of its early diagnosis.

KW - Alzheimer’s disease

KW - beta-amyloid protein

KW - curcumin

KW - eye

KW - mild cognitive impairment

KW - retina

KW - scanning laser ophthalmoscopy

UR - https://www.mendeley.com/catalogue/300ec74a-d50a-3c14-b352-b64d740ade94/

U2 - 10.17116/jnevro202512504219

DO - 10.17116/jnevro202512504219

M3 - статья

VL - 125

SP - 19

EP - 25

JO - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА

JF - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА

SN - 1997-7298

IS - 4-2

ER -

ID: 135965987